Alexandria, VA USA
San Jose, CA USA
The United States Patent and Trademark Office (USPTO) hosts their first-ever bi-coastal collaborative forum for the biotech, chemical and pharma industry sector. Interact with USPTO personnel from both coasts in person or via webcast. Learn more > > >
Check out these exciting new videos that showcase a commercialized invention and feature a person who benefited from that technology! They’re the first videos released from AUTM’s Put A Face On It video award program.
Sept. 18 – 19
Baltimore, Maryland, USA
Join more than 200 technology transfer professionals to discuss best practices and strategies for industry-academia partnerships and commercialization.
“…the metaphor of “a troll lurking under the technology bridge” aptly describes a recent flare-up in the business of getting discoveries across that bridge into the marketplace.”
Also read "Coalition Patent Letter"
Signed by a diverse group of university licensees and others concerned with the direction of patent legislation.
Oct. 2 – 3
Seattle, Washington, USA
Join colleagues from the western United States and Canada for an exciting program of educational and networking events designed to provide insights for experienced and new technology transfer professionals.Learn more > > >
Help us reach our goal of 500 technologies in the Better World Project database and you could win $100!
Get instant access to helpful resources, networking and discounts on AUTM events.
View member benefits »
Get involved by supporting a committee that suits your interests and availability.
The AUTM Nominations and Awards Committee is pleased to invite all AUTM members to submit nominations for candidates to serve on the 2015 AUTM Board of Directors for the following positions:
H8 Sharing Data and Assets Across Industry and Academia to Drive the Science Base and Innovation
|Track:||Industry - Academic Relations|
|Target Audience:||All Audiences|
|Moderator:||Malcolm Skingle, Ph.D., GlaxoSmithKline|
|Speakers:||Rowan Douglas, Willis Research Network|
|Helene Rutledge , GlaxoSmithKline|
|Bin Yan, Ph.D., LL.B. , University of Miami W.H Coulter Center|
Increasingly, technology-driven companies are looking to de-risk research and development projects by sharing data and proprietary assets with selected academics in order to expand parts of the science base and to increase their internal knowledge. Many of these projects are co-funded by funding agencies on the assumption that the data generated is deposited into the public domain for all to access. This has driven an interesting dynamic where the corporate company has wanted increased levels of openness and some universities wish to adopt a more secretive approach. Several companies driven by global technology have developed innovative business models with certain universities in recent years in order to increase R&D productivity. These models will be described in detail in order to share what many in industries now consider to be best practice. Recent novel examples from different industrial sectors will be described, including business models from GlaxoSmithKline, Proctor and Gamble, and Willis Ltd, a company specializing in risk adjustment.